Tech Company Financing Transactions
Oxford Endovascular Funding Round
On 5/20/2024, Oxford Endovascular raised $10.2 million in Series A funding from ParkWalk Advisors, Norcliffe Capital and Oxford Science Enterprises.
Transaction Overview
Company Name
Announced On
5/20/2024
Transaction Type
Venture Equity
Amount
$10,200,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to take its medical device, OXIFLOW, a step closer to a First-In-Human clinical study, and furter scale up operations.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
G4 Magdalen Centre, Robert Robinson Avenue, Oxford Science P
Oxford, OX4 4GA
UK
Oxford, OX4 4GA
UK
Phone
Undisclosed
Website
Email Address
Overview
Oxford Endovascular Ltd is a spin-out from Oxford University, working to prevent brain haemorrhage by curing brain aneurysms, a condition that affects 1 in 50 persons. OxiFlow is a novel, next generation flow-diverter, that diverts blood flow away from intracranial aneurysms at risk of rupture. It places more accurately and safely than existing devices, reducing the risk of complications. It conforms better to blood vessels making more patients treatable
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Chas Taylor
Chief Executive Officer
Mike Karim
Chief Technical Officer
Zhong You
Browse more venture capital transactions:
Prev: 5/20/2024: 280 Earth venture capital transaction
Next: 5/20/2024: R3 Vascular venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs